Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data reported for S*BIO's SB-939

Nov. 21, 2011

Promising preclinical results presented for LDK-378

Nov. 18, 2011

Protein linked to prognosis of adenocarcinomas of the lung

Nov. 18, 2011

EZN-3042 administered with docetaxel in phase I study

Nov. 18, 2011

Anti-alpha-V/beta-6 antibody inhibits liver fibrosis

Nov. 18, 2011

ONO-2952 emerges as a potential treatment for stress-related disorders

Nov. 18, 2011

Favorable preclinical profile of C-21191 supports development for pain, spasticity

Nov. 17, 2011

EB-1020 as a new approach to treat ADHD

Nov. 17, 2011

Achillion Pharmaceuticals describes second-generation NS5A inhibitors

Nov. 17, 2011

Preclinical profile of Merck & Co.'s HCV NS5A inhibitor MK-4882 described

Nov. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...